ban on compounded tirzepatide Will Be Banned? FDA ban on compounded tirzepatide:

If reflux or other GI effects are making treatment feel harder than expected, GLP-1 medication education can help you understand the connection between slower emptying and symptom management

The conversation covers how our understanding of obesity as a chronic, relapsing disease has changed over the past 30 years, what the new clinical versus preclinical obesity framework means for how we diagnose and treat it, how GLP-1 drugs work and why they've succeeded where earlier medications failed, what the STEP and SELECT trials revealed about the disease-modifying potential of semaglutide, and how patients and clinicians should be thinking about who these drugs are really for

Wong SY, Lee ARYB, Sia AHJ et al (2024) Effects of Glucagon-Like Peptide-1 receptor agonist (GLP-1RA) on cardiac structure and function: A systematic review and meta-analysis of randomized-controlled trials

Moreover, in recent years, NAFLD has evolved from an isolated liver condition to a systemic disease with significant manifestations beyond the liver

"You forget how dark you are," he said